Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 18, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Prostate CancerBladder CancerKidney Cancer
Interventions
OTHER

questionnaires

"Anamnestic and socio-demographic information will be collected through a generic self-designed questionnaire including the following data: age, sex, residence (within or outside the Veneto region), marital status (married, divorced, cohabiting, single, widowed), employment status (employed, unemployed, retired), presence of dependents (yes/no), level of education (defined as primary, middle or high school, university degree), concomitant pathologies.~Additional data on the oncological history are also reported: histology and staging of the disease, presence or absence of metastatic disease, additional treatments before or after surgery (e.g. neoadjuvant treatments, adjuvant treatments, radiotherapy)."

Trial Locations (1)

35128

RECRUITING

Istituto Oncologico Veneto, Padua

All Listed Sponsors
lead

Istituto Oncologico Veneto IRCCS

OTHER

NCT06955910 - Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies. | Biotech Hunter | Biotech Hunter